Estudo do perfil dos usuários de PREP (profilaxia pré-exposição ao HIV) no Município de Cascavel
Open Access
- 8 November 2022
- journal article
- Published by Research, Society and Development in Research, Society and Development
- Vol. 11 (15)
Abstract
Seen as a new way of not contracting the Human Immunodeficiency Virus (HIV), which causes a notifiable disease, the daily taking of a pill, legally prescribed and indicated by a medical professional specialized in the area, seeks pre -exposure to the virus in patients belonging to risk groups. A medication recently implemented and accepted on the list of approved drugs and distributed free of charge to the population through the Unified Health System (SUS), by the National Health Surveillance Agency (ANVISA). Due to the great impact on the patients' quality of life and socioeconomic factors, this study seeks to analyze which population groups are candidates for the use of medication, recognized and approved by the Ministry of Health and how they are distributed in society, analyzing the epidemiological profile of patients, in Municipality of Cascavel – Paraná, in comparison with the numbers of the state of Paraná and the country Brazil. From the interpretation of the data, collected from an electronic address provided by the department of diseases, chronic conditions and sexually transmitted infections of the ministry of health, recognize the possibility of maintaining or establishing new measures in search of a more complete and optimized treatment in favor of wellfare of the patient.Keywords
This publication has 10 references indexed in Scilit:
- Uso da Profilaxia Pré-Exposição (PrEP) como PREVENÇÃO COMBINADA na contenção da disseminação do Vírus da Imunodeficiência Humana (HIV) em grupos de riscoRevista Eletrônica Acervo Saúde, 2022
- Conhecimentos, práticas e obstáculos dos profissionais de saúde sobre a profilaxia pré-exposição ao HIV (PREP): uma revisão integrativa / Health professionals' knowledge and obstacles about HIV pre-exposure prophylaxis (PREP): an integrative reviewBrazilian Journal of Development, 2022
- Profilaxia pré-exposição ao HIV/AIDS: análise situacional após 03 anos de disponibilidade no Sistema Único de Saúde (SUS)Research, Society and Development, 2022
- Eficácia e segurança da PrEP na prevenção da infecção pelo HIV entre populações-chave: uma revisão integrativa/ Effectiveness and safety of PrEP in preventing HIV infection among key populations: an integrative reviewBrazilian Journal of Development, 2021
- Análise Da Profilaxia Pré-Exposição Para HivBrazilian Journal of Development, 2019
- Da evidência à ação: desafios do Sistema Único de Saúde para ofertar a profilaxia pré-exposição sexual (PrEP) ao HIV às pessoas em maior vulnerabilidadeCadernos de Saude Publica, 2018
- High pre‐exposure prophylaxis uptake and early adherence among men who have sex with men and transgender women at risk for HIV Infection: the PrEP Brasil demonstration projectJournal of the International AIDS Society, 2017
- Combination implementation for HIV prevention: moving from clinical trial evidence to population-level effectsThe Lancet Infectious Diseases, 2013
- Pharmacological considerations for tenofovir and emtricitabine to prevent HIV infectionJournal of Antimicrobial Chemotherapy, 2010
- Qualidade de vida de indivíduos com HIV/AIDS: uma revisão de literaturaRevista Latino-Americana de Enfermagem, 2004